Xilio Therapeutics, Inc. (XLO)
Nasdaq: XLO · Pharmaceutical Preparations · Waltham, MA · filing with the SEC since 2021
The company now
Xilio Therapeutics, Inc. is classed by the SEC under Pharmaceutical Preparations (industry code 2834), based in Waltham, MA. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $44 million and a loss of $35 million (its filed statements).
From its filings and filed figures; the desk's account of it is not written yet.
The desk's written account, its read of the annual report, the record in brief and the split of the revenue are not on file for this company yet.